COLL

Collegium Pharmaceutical, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →

YES
19.8% BELOW
↑ Moving away Was -23.4% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $31.58
14-Week RSI 32
Rel. Volume (14w) This week's trading vs. the 14-week average 0.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.93

Collegium Pharmaceutical, Inc. (COLL) closed at $25.32 as of 2026-11-13, trading 19.8% below its 200-week moving average of $31.58. This places COLL in the extreme value zone. The stock moved further from the line this week, up from -23.4% last week. The 14-week RSI sits at 32, indicating neutral momentum.

Trading volume is running at 0.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.93 ratio) is neutral — neither side is clearly dominating.

Over the past 553 weeks of data, COLL has crossed below its 200-week moving average 15 times. On average, these episodes lasted 13 weeks. Historically, investors who bought COLL at the start of these episodes saw an average one-year return of +13.9%.

With a market cap of $787 million, COLL is a small-cap stock. The company generates a free cash flow yield of 46.6%, which is notably high. Return on equity stands at 13.4%. The stock trades at 2.6x book value.

The company has been aggressively buying back shares, reducing its share count by 6.3% over the past three years.

Over the past 10.7 years, a hypothetical investment of $100 in COLL would have grown to $133, compared to $432 for the S&P 500. COLL has returned 2.7% annualized vs 14.7% for the index, underperforming the broader market over this period.

Free cash flow has been growing at a 38.8% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: COLL vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After COLL Crosses Below the Line?

Across 15 historical episodes, buying COLL when it crossed below its 200-week moving average produced an average return of +12.0% after 12 months (median +31.0%), compared to +14.7% for the S&P 500 over the same periods. 64% of those episodes were profitable after one year. After 24 months, the average return was +40.4% vs +32.1% for the index.

Each line shows $100 invested at the moment COLL crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices COLL would reach each dislocation threshold.

Current Bean Score -1.44σ
Current FCF Yield 42.74%
Baseline Yield 49.15%
Historical σ 8.66pp

Dislocation Price Levels

Prices where COLL's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$14.92Unusually cheap — analysis point
Value+1σ$16.94Cheap vs. own history
Fair Value+0σ$19.59Historical mean behavior
Expensive-1σ$23.24Expensive vs. own history
Deep Expensive-2σ$28.55Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-11-05$1.86$1.96+5.6%
2026-08-06$1.77$1.92+8.8%
2026-05-07$1.52$1.76+15.5%
2026-02-26$2.14$2.04-4.7%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from COLL's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +1.14σ Distance from line vs own history
Sector-Relative +0.04σ Vs sector median this week
Buyback Acceleration +3.0pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +24.1pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-3.4pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

COLL has crossed below its 200-week MA 15 times with an average 1-year return of +13.9% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 2016Sep 20162448.5%-46.1%+36.6%
Oct 2016Nov 20175550.9%-34.7%+66.3%
Aug 2018Oct 2018712.8%-31.6%+50.4%
Oct 2018Nov 201848.7%-29.5%+54.4%
Dec 2018Feb 20191014.8%+33.2%+71.3%
Mar 2019Nov 20193337.3%-9.7%+60.3%
Mar 2020Mar 2020111.2%+80.3%+77.6%
Jun 2020Jun 202011.0%+54.7%+55.0%
Jul 2020Aug 202015.0%+57.7%+60.5%
Aug 2021Aug 202116.3%+5.9%+42.6%
Nov 2021Feb 2022158.0%-1.2%+32.8%
Feb 2022Mar 202228.1%+50.5%+41.5%
Apr 2022Aug 20221520.3%+30.7%+43.5%
Aug 2022Oct 20221113.2%+34.1%+42.1%
Aug 2026Ongoing15+30.3%Ongoing-14.1%
Average13—+13.9%—

Frequently Asked Questions

Is COLL below its 200-week moving average?

Yes. As of 2026-11-13, Collegium Pharmaceutical, Inc. (COLL) is trading 19.8% below its 200-week moving average of $31.58. The current price is $25.32.

What is COLL's 200-week moving average price?

Collegium Pharmaceutical, Inc.'s 200-week moving average is $31.58 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when COLL drops below its 200-week moving average?

COLL has crossed below its 200-week moving average 15 times in our data. On average, buying at that moment produced a one-year return of +13.9%. These dips have historically been decent entry points. These episodes lasted 13 weeks on average.

Is COLL a good value right now?

Here's what our data says about COLL as of 2026-11-13: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 32. Free cash flow yield is 46.6%. Return on equity is 13.4%. Price-to-book is 2.6x. This is not a buy or sell recommendation — always do your own research.

How does COLL compare to the S&P 500?

Over the past 10.7 years, $100 invested in COLL would have grown to $133, compared to $432 for the S&P 500. That's 2.7% annualized vs 14.7% for the index. COLL has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13